Direct effect of GLP-1 infusion on endogenous glucose production in humans - PubMed (original) (raw)

Controlled Clinical Trial

doi: 10.1007/s00125-012-2738-3. Epub 2012 Oct 12.

Affiliations

Controlled Clinical Trial

Direct effect of GLP-1 infusion on endogenous glucose production in humans

M Seghieri et al. Diabetologia. 2013 Jan.

Abstract

Aims/hypothesis: Glucagon-like peptide-1 (GLP-1) lowers glucose levels by potentiating glucose-induced insulin secretion and inhibiting glucagon release. The question of whether GLP-1 exerts direct effects on the liver, independently of the hormonal changes, is controversial. We tested whether an exogenous GLP-1 infusion, designed to achieve physiological postprandial levels, directly affects endogenous glucose production (EGP) under conditions mimicking the fasting state in diabetes.

Methods: In 14 healthy volunteers, we applied the pancreatic clamp technique, whereby plasma insulin and glucagon levels are clamped using somatostatin and hormone replacement. The clamp was applied in paired, 4 h experiments, during which saline (control) or GLP-1(7-37)amide (0.4 pmol min⁻¹ kg⁻¹) was infused.

Results: During the control study, plasma insulin and glucagon were maintained at basal levels and plasma C-peptide was suppressed, such that plasma glucose rose to a plateau of ~10.5 mmol/l and tracer-determined EGP increased by ~60%. During GLP-1 infusion at matched plasma glucose levels, the rise of EGP from baseline was fully prevented. Lipolysis (as indexed by NEFA concentrations and tracer-determined glycerol rate of appearance) and substrate utilisation (by indirect calorimetry) were similar between control and GLP-1 infusion.

Conclusions/interpretation: GLP-1 inhibits EGP under conditions where plasma insulin and glucagon are not allowed to change and glucose concentrations are matched, indicating either a direct effect on hepatocytes or neurally mediated inhibition.

PubMed Disclaimer

References

    1. Regul Pept. 2011 Apr 11;167(2-3):177-84 - PubMed
    1. Diabetes. 2001 Mar;50(3):565-72 - PubMed
    1. Am J Physiol Endocrinol Metab. 2003 Oct;285(4):E701-7 - PubMed
    1. Diabetes. 2000 Apr;49(4):611-7 - PubMed
    1. Regul Pept. 2011 Jun 7;168(1-3):39-44 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources